{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:51:11Z","timestamp":1732038671645},"reference-count":90,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10777","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T06:30:28Z","timestamp":1572417028000},"source":"Crossref","is-referenced-by-count":3,"title":["HIV\u20111 integrase inhibitors targeting various DDE transposases: Retroviral integration versus RAG\u2011mediated recombination (Review)"],"prefix":"10.3892","author":[{"given":"Mihaela","family":"Mu\u0219at","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ni\u021bulescu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Surleac","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u2018Matei Bals\u2019, 021105 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristidis","family":"Tsatsakis","sequence":"additional","affiliation":[{"name":"Department of Forensic Sciences and Toxicology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisa","family":"Margin\u0103","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 020956 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"key20200713234129_b1-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1101\/gr.5826307","article-title":"The evolutionary history of human DNA transposons: Evidence for intense activity in the primate lineage","volume":"17","author":"Pace","year":"2007","journal-title":"Genome Res"},{"key":"key20200713234129_b2-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.tig.2017.07.011","article-title":"Transposable Element Domestication As an Adaptation to Evolutionary Conflicts","volume":"33","author":"Jangam","year":"2017","journal-title":"Trends Genet"},{"key":"key20200713234129_b3-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"18075","DOI":"10.1073\/pnas.0503676102","article-title":"The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b4-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"12758","DOI":"10.1021\/acs.chemrev.6b00003","article-title":"DNA Transposition at Work","volume":"116","author":"Hickman","year":"2016","journal-title":"Chem Rev"},{"key":"key20200713234129_b5-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1073\/pnas.36.6.344","article-title":"The origin and behavior of mutable loci in maize","volume":"36","author":"McCLINTOCK","year":"1950","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b6-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrmicro3067","article-title":"Breaking and joining single-stranded DNA: The HUH endonuclease superfamily","volume":"11","author":"Chandler","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"key20200713234129_b7-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nrg2165","article-title":"A unified classification system for eukaryotic transposable elements","volume":"8","author":"Wicker","year":"2007","journal-title":"Nat Rev Genet"},{"key":"key20200713234129_b8-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1073\/pnas.1104208108","article-title":"The catalytic domain of all eukaryotic cut-and-paste transposase superfamilies","volume":"108","author":"Yuan","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b9-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/nprot.2011.363","article-title":"FLP\/FRT-mediated conditional mutagenesis in pre-erythrocytic stages of Plasmodium berghei","volume":"6","author":"Lacroix","year":"2011","journal-title":"Nat Protoc"},{"key":"key20200713234129_b10-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3892\/mmr.2014.2793","article-title":"Reprogramming rat embryonic fibroblasts into induced pluripotent stem cells using transposon vectors and their chondrogenic differentiation in vitro","volume":"11","author":"Ye","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713234129_b11-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/86166","article-title":"Comparative architecture of transposase and integrase complexes","volume":"8","author":"Rice","year":"2001","journal-title":"Nat Struct Biol"},{"key":"key20200713234129_b12-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri2941","article-title":"Recombination centres and the orchestration of V(D)J recombination","volume":"11","author":"Schatz","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"key20200713234129_b13-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1128\/MCB.25.11.4413-4425.2005","article-title":"Determinants of HMGB proteins required to promote RAG1\/2-recombination signal sequence complex assembly and catalysis during V(D)J recombination","volume":"25","author":"Dai","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key20200713234129_b14-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"e2852","DOI":"10.1038\/cddis.2017.237","article-title":"HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination","volume":"8","author":"Nishana","year":"2017","journal-title":"Cell Death Dis"},{"key":"key20200713234129_b15-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/AAC.01413-10","article-title":"Integrase inhibitors effective against human T-cell leukemia virus type 1","volume":"55","author":"Seegulam","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key20200713234129_b16-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"16078","DOI":"10.1073\/pnas.1007144107","article-title":"Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain","volume":"107","author":"Nadal","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b17-mmr-20-06-4749","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"key20200713234129_b18-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature14174","article-title":"Crystal structure of the V(D)J recombinase RAG1-RAG2","volume":"518","author":"Kim","year":"2015","journal-title":"Nature"},{"key":"key20200713234129_b19-mmr-20-06-4749","unstructured":"AvogadroAvogadro: an open-source molecular builder and visualization tool. Version 1.0.3http:\/\/AvogadroOpenmoleculesNet\/2012"},{"key":"key20200713234129_b20-mmr-20-06-4749","author":"DeLano","year":"2002"},{"key":"key20200713234129_b21-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.molcel.2018.03.008","article-title":"Cracking the DNA Code for V(D)J Recombination","volume":"70","author":"Kim","year":"2018","journal-title":"Mol Cell"},{"key":"key20200713234129_b22-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0092-8674(02)00671-2","article-title":"Hairpin opening and overhang processing by an Artemis\/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination","volume":"108","author":"Ma","year":"2002","journal-title":"Cell"},{"key":"key20200713234129_b23-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.cell.2015.10.055","article-title":"Molecular Mechanism of V(D)J Recombination from Synaptic RAG1-RAG2 Complex Structures","volume":"163","author":"Ru","year":"2015","journal-title":"Cell"},{"key":"key20200713234129_b24-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.molcel.2009.12.035","article-title":"The RING domain of RAG1 ubiquitylates histone H3: A novel activity in chromatin-mediated regulation of V(D)J joining","volume":"37","author":"Grazini","year":"2010","journal-title":"Mol Cell"},{"key":"key20200713234129_b25-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nature06431","article-title":"RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination","volume":"450","author":"Matthews","year":"2007","journal-title":"Nature"},{"key":"key20200713234129_b26-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cell.2016.05.032","article-title":"Discovery of an Active RAG Transposon Illuminates the Origins of V(D)J Recombination","volume":"166","author":"Huang","year":"2016","journal-title":"Cell"},{"key":"key20200713234129_b27-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41586-019-1093-7","article-title":"Transposon molecular domestication and the evolution of the RAG recombinase","volume":"569","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"key20200713234129_b28-mmr-20-06-4749","first-page":"1463","article-title":"Aberrant V(D)J cleavages in T cell receptor \u03b2 enhancer- and p53-deficient lymphoma cells","volume":"23","author":"Kang","year":"2010","journal-title":"Oncol Rep"},{"key":"key20200713234129_b29-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1128\/MCB.17.6.3125","article-title":"Cryptic signals and the fidelity of V(D)J joining","volume":"17","author":"Lewis","year":"1997","journal-title":"Mol Cell Biol"},{"key":"key20200713234129_b30-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"key":"key20200713234129_b31-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/emboj\/cdg137","article-title":"In vivo transposition mediated by V(D)J recombinase in human T lymphocytes","volume":"22","author":"Messier","year":"2003","journal-title":"EMBO J"},{"key":"key20200713234129_b32-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1101\/gad.1432706","article-title":"Genomic instability due to V(D)J recombination-associated transposition","volume":"20","author":"Reddy","year":"2006","journal-title":"Genes Dev"},{"key":"key20200713234129_b33-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3892\/ijmm.2012.1088","article-title":"Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9","volume":"30","author":"Li","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20200713234129_b34-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"e1002584","DOI":"10.1371\/journal.pbio.1002584","article-title":"Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase","volume":"14","author":"Gupta","year":"2016","journal-title":"PLoS Biol"},{"key":"key20200713234129_b35-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrmicro.2017.22","article-title":"Nuclear landscape of HIV-1 infection and integration","volume":"15","author":"Lusic","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"key20200713234129_b36-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1073\/pnas.150220297","article-title":"Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding","volume":"97","author":"Chen","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b37-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1126\/science.2169648","article-title":"Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein","volume":"249","author":"Yang","year":"1990","journal-title":"Science"},{"key":"key20200713234129_b38-mmr-20-06-4749","first-page":"1987","article-title":"Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review)","volume":"19","author":"Venanzi Rullo","year":"2019","journal-title":"Mol Med Rep"},{"key":"key20200713234129_b39-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1021\/jm000176b","article-title":"4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells","volume":"43","author":"Wai","year":"2000","journal-title":"J Med Chem"},{"key":"key20200713234129_b40-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.287.5453.646","article-title":"Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells","volume":"287","author":"Hazuda","year":"2000","journal-title":"Science"},{"key":"key20200713234129_b41-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1021\/jm800245z","article-title":"Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection","volume":"51","author":"Summa","year":"2008","journal-title":"J Med Chem"},{"key":"key20200713234129_b42-mmr-20-06-4749","unstructured":"U.S. Food & Drug AdministrationHIV Timeline and History of Approvalshttps:\/\/www.fda.gov\/patients\/hivaids\/hiv-timeline-and-history-approvalsAugust12018"},{"key":"key20200713234129_b43-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/jm400674a","article-title":"Inhibiting the HIV integration process: Past, present, and the future","volume":"57","author":"Di Santo","year":"2014","journal-title":"J Med Chem"},{"key":"key20200713234129_b44-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1021\/jm0600139","article-title":"Novel HIV-1 integrase inhibitors derived from quinolone antibiotics","volume":"49","author":"Sato","year":"2006","journal-title":"J Med Chem"},{"key":"key20200713234129_b45-mmr-20-06-4749","first-page":"5","article-title":"Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings","volume":"4","author":"Lee","year":"2012","journal-title":"HIV AIDS (Auckl)"},{"key":"key20200713234129_b46-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9745\/GHSP-D-14-00243","article-title":"ARVs: The next generation. Going boldly together to new frontiers of HIV treatment","volume":"3","author":"Barnhart","year":"2015","journal-title":"Glob Health Sci Pract"},{"key":"key20200713234129_b47-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1021\/jm400645w","article-title":"Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S\/GSK1349572) and (S\/GSK1265744)","volume":"56","author":"Johns","year":"2013","journal-title":"J Med Chem"},{"key":"key20200713234129_b48-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature08784","article-title":"Retroviral intasome assembly and inhibition of DNA strand transfer","volume":"464","author":"Hare","year":"2010","journal-title":"Nature"},{"key":"key20200713234129_b49-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1124\/mol.111.073189","article-title":"Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S\/GSK1349572)","volume":"80","author":"Hare","year":"2011","journal-title":"Mol Pharmacol"},{"key":"key20200713234129_b50-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1128\/AAC.00157-11","article-title":"Dolutegravir (S\/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes","volume":"55","author":"Hightower","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key20200713234129_b51-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/AAC.03909-14","article-title":"Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection","volume":"59","author":"Yoshinaga","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key20200713234129_b52-mmr-20-06-4749","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1128\/AAC.01474-16","article-title":"Antiviral activity of bictegravir (GS-9883), a novel potent HIV-1 integrase strand transfer inhibitor with an improved resistance profile","volume":"60","author":"Tsiang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key20200713234129_b53-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1021\/jm980043e","article-title":"Styrylquinoline derivatives: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells","volume":"41","author":"Mekouar","year":"1998","journal-title":"J Med Chem"},{"key":"key20200713234129_b54-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1124\/mol.65.1.85","article-title":"Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro","volume":"65","author":"Deprez","year":"2004","journal-title":"Mol Pharmacol"},{"key":"key20200713234129_b55-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.antiviral.2013.04.001","article-title":"Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors","volume":"98","author":"Han","year":"2013","journal-title":"Antiviral Res"},{"key":"key20200713234129_b56-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1128\/JVI.78.11.5728-5736.2004","article-title":"Styrylquinolines, integrase inhibitors acting prior to integration: A new mechanism of action for anti-integrase agents","volume":"78","author":"Bonnenfant","year":"2004","journal-title":"J Virol"},{"key":"key20200713234129_b57-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aah5163","article-title":"Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome","volume":"355","author":"Passos","year":"2017","journal-title":"Science"},{"key":"key20200713234129_b58-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"e0128310","DOI":"10.1371\/journal.pone.0128310","article-title":"Structural studies of the HIV-1 integrase protein: Compound screening and characterization of a DNA-binding inhibitor","volume":"10","author":"Quashie","year":"2015","journal-title":"PLoS One"},{"key":"key20200713234129_b59-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1073\/pnas.0400873101","article-title":"Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry","volume":"101","author":"Shkriabai","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b60-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/j.1745-7254.2008.00863.x","article-title":"Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase","volume":"29","author":"Du","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"key20200713234129_b61-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.1093\/emboj\/17.22.6723","article-title":"Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation","volume":"17","author":"Ge","year":"1998","journal-title":"EMBO J"},{"key":"key20200713234129_b62-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"33528","DOI":"10.1074\/jbc.M303594200","article-title":"LEDGF\/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells","volume":"278","author":"Maertens","year":"2003","journal-title":"J Biol Chem"},{"key":"key20200713234129_b63-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"55570","DOI":"10.1074\/jbc.M408508200","article-title":"Lens epithelium-derived growth factor\/p75 prevents proteasomal degradation of HIV-1 integrase","volume":"279","author":"Llano","year":"2004","journal-title":"J Biol Chem"},{"key":"key20200713234129_b64-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1128\/JVI.00801-06","article-title":"Overexpression of the lens epithelium-derived growth factor\/p75 integrase binding domain inhibits human immunodeficiency virus replication","volume":"80","author":"De Rijck","year":"2006","journal-title":"J Virol"},{"key":"key20200713234129_b65-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"17308","DOI":"10.1073\/pnas.0506924102","article-title":"Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75","volume":"102","author":"Cherepanov","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b66-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2008.07.139","article-title":"D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF\/p75","volume":"375","author":"Du","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713234129_b67-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nchembio.370","article-title":"Rational design of small-molecule inhibitors of the LEDGF\/p75-integrase interaction and HIV replication","volume":"6","author":"Christ","year":"2010","journal-title":"Nat Chem Biol"},{"key":"key20200713234129_b68-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1021\/ml500002n","article-title":"Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1","volume":"5","author":"Fader","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"key20200713234129_b69-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"21189","DOI":"10.1074\/jbc.M112.347534","article-title":"New class of HIV-1 integrase (IN) inhibitors with a dual mode of action","volume":"287","author":"Tsiang","year":"2012","journal-title":"J Biol Chem"},{"key":"key20200713234129_b70-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1073\/pnas.012610699","article-title":"Effect of HIV integrase inhibitors on the RAG1\/2 recombinase","volume":"99","author":"Melek","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b71-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"13040","DOI":"10.1073\/pnas.96.23.13040","article-title":"Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design","volume":"96","author":"Goldgur","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b72-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/14740338.2018.1411903","article-title":"A safety evaluation of raltegravir for the treatment of HIV","volume":"17","author":"de Miguel","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"key20200713234129_b73-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1742-6405-7-44","article-title":"Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution","volume":"7","author":"Huhn","year":"2010","journal-title":"AIDS Res Ther"},{"key":"key20200713234129_b74-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMoa0708975","article-title":"Raltegravir with optimized background therapy for resistant HIV-1 infection","volume":"359","author":"Steigbigel","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200713234129_b75-mmr-20-06-4749","first-page":"1121","article-title":"HIV infection and cancer in the era of highly active antiretroviral therapy (Review)","volume":"17","author":"Barbaro","year":"2007","journal-title":"Oncol Rep"},{"key":"key20200713234129_b76-mmr-20-06-4749","article-title":"sNDA 207561\/S-014. Genvoya (elvitegravir\/cobicistat\/emtricitabine\/tenofovir alafenamide)","author":"Gillead","journal-title":"Clinical and Cross-Discipline Team Leader Review"},{"key":"key20200713234129_b77-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1128\/MCB.22.10.3460-3473.2002","article-title":"Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase","volume":"22","author":"Huye","year":"2002","journal-title":"Mol Cell Biol"},{"key":"key20200713234129_b78-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.289.5476.77","article-title":"Three-dimensional structure of the Tn5 synaptic complex transposition intermediate","volume":"289","author":"Davies","year":"2000","journal-title":"Science"},{"key":"key20200713234129_b79-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1128\/AAC.49.5.2035-2043.2005","article-title":"Targeting Tn5 transposase identifies human immunodeficiency virus type 1 inhibitors","volume":"49","author":"Ason","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key20200713234129_b80-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"10776","DOI":"10.1021\/bi7006542","article-title":"Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors","volume":"46","author":"Czyz","year":"2007","journal-title":"Biochemistry"},{"key":"key20200713234129_b81-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/JVI.02541-10","article-title":"Differential sensitivities of retroviruses to integrase strand transfer inhibitors","volume":"85","author":"Koh","year":"2011","journal-title":"J Virol"},{"key":"key20200713234129_b82-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"20865","DOI":"10.1073\/pnas.0908074106","article-title":"Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir","volume":"106","author":"Beck-Engeser","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713234129_b83-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"key20200713234129_b84-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1021\/cb400791u","article-title":"Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir","volume":"9","author":"Wolkowicz","year":"2014","journal-title":"ACS Chem Biol"},{"key":"key20200713234129_b85-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10709-010-9452-1","article-title":"Metnase\/SETMAR: A domesticated primate transposase that enhances DNA repair, replication, and decatenation","volume":"138","author":"Shaheen","year":"2010","journal-title":"Genetica"},{"key":"key20200713234129_b86-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-12-0313","article-title":"Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapy","volume":"72","author":"Williamson","year":"2012","journal-title":"Cancer Res"},{"key":"key20200713234129_b87-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fmicb.2018.00925","article-title":"Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma","volume":"9","author":"Marino-Merlo","year":"2018","journal-title":"Front Microbiol"},{"key":"key20200713234129_b88-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1128\/AAC.01361-07","article-title":"Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication","volume":"52","author":"Rabaaoui","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key20200713234129_b89-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/JVI.01534-07","article-title":"Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303\/GS-9137)","volume":"82","author":"Shimura","year":"2008","journal-title":"J Virol"},{"key":"key20200713234129_b90-mmr-20-06-4749","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aah5163","article-title":"Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome","volume":"355","author":"Passos","year":"2017","journal-title":"Science"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T22:58:11Z","timestamp":1721948291000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":90,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10777","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]}}}